KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

Lung neoplasms are the leading cause of death by cancer worldwide. Non-small cell lung cancer (NSCLC) constitutes more than 80% of all lung malignancies and the majority of patients present advanced disease at onset. However, in the last decade, multiple oncogenic driver alterations have been discov...

Descripción completa

Detalles Bibliográficos
Autores principales: Román, Marta, Baraibar, Iosune, López, Inés, Nadal, Ernest, Rolfo, Christian, Vicent, Silvestre, Gil-Bazo, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817724/
https://www.ncbi.nlm.nih.gov/pubmed/29455666
http://dx.doi.org/10.1186/s12943-018-0789-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817724/
https://www.ncbi.nlm.nih.gov/pubmed/29455666
http://dx.doi.org/10.1186/s12943-018-0789-x

Ejemplares similares